Litcius/Paper detail

Safety, tolerability, and immunogenicity of an adult pneumococcal conjugate vaccine, V116 (STRIDE-3): a randomised, double-blind, active comparator controlled, international phase 3 trial

Heather Platt, Christopher Bruno, Erik Buntinx, Enrique Pelayo, Diego Garcia‐Huidobro, Elizabeth A Barranco-Santana, Folke Sjöberg, Joon Young Song, Carlos G. Grijalva, Walter A. Orenstein, Leslie Morgan, Doreen Fernsler, Weifeng Xu, Muhammad Waleed, Jianing Li, Ulrike K. Buchwald, Michael Abdel-Malek, Jeffrey Adelglass, Sady Alpizar, Duane C. Anderson, Charles P. Andrews, Helena Hervius Askling, Jeffrey B. Baker, Mira Baron, Elizabeth A Barranco-Santana, John Beckes, James H. Bergthold, Peter Bosson, Erik Buntinx, Larry M. Bush, David Butuk, Edgardo F. Cartagena Ayala, Hee Jung Choi, Jung‐Hyun Choi, Won Suk Choi, Young Hwa Choi, James R. Clark, Oliver A. Cornely, Steve E. Cox, Nizar Daboul, Luis I. De La Cruz, Pamela De Silva, Olaf Degen, Valentine M. Ebuh, Stanton R. Elzi, Thomas Fiel, William Fitzgibbons, Neil J. Fraser, George Hartley Freeman, Christopher Galloway, Diego Garcia‐Huidobro, Juan Carlos Garza, Anil George, Carl Griffin, Sridhar Guduri, Rahmet Güner, Elizabeth Gunner, Enrique Hanabergh, Charles Harper, Kathleen Mullan Harris, John Hemmersmeier, John M. Hill, Ching‐Tai Huang, Kuo‐Chin Huang, Chad Roger Huberty, Bejamin James Image, Margret Jandl, Jr. Johnston William Henry, Jackie Kamerbeek, Oğuz Karabay, Jae‐Hoon Ko, İftihar Köksal, Ki Tae Kwon, Amber Leah, Dong‐Gun Lee, Jacob Lee, Thomas Lenzmeier, Denissa Loh, Rafael Lupercio, A. Luts, Thomas A. Lutz, José Luis Martínez, Renae Mayer, Vicki E. Miller, Javier O Morales-Ramirez, Manuel Múñoz, Jesus Ovidio Navarro, Larry Lee Odekirk, Patrick Odia, Alberto Odio, Matthew O’Sullivan, Minesh Arun Patel, Enrique Pelayo, Carlos Perez Cortes, Syed Pervaiz, J Probst, Dean Richard Quinn, Kathryn R. Rigonan, Nicolas Rosario-Matos, Jeffrey B. Rosen

2024The Lancet Infectious Diseases54 citationsDOI

Topics & Concepts

TolerabilityImmunogenicityMedicinePneumococcal conjugate vaccinePneumococcal diseaseConjugatePediatricsInternal medicineImmunologyAdverse effectAntibodyStreptococcus pneumoniaeBiologyMicrobiologyMathematical analysisAntibioticsMathematicsPneumonia and Respiratory InfectionsRespiratory viral infections researchInfluenza Virus Research Studies
Safety, tolerability, and immunogenicity of an adult pneumococcal conjugate vaccine, V116 (STRIDE-3): a randomised, double-blind, active comparator controlled, international phase 3 trial | Litcius